CNTY-103

N/A

Report date: 2023/01/12 16:09:02

Base Information

Drug NameCNTY-103
Drug Alias NameCNTY103
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionImmunologic cytotoxicityNatural killer cell replacements
TargetsUpdating
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCentury Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesCentury Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A